The JNKs differentially regulate RNA polymerase III transcription by coordinately modulating the expression of all TFIIIB subunits

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 31, 2009, Pages 12682-12687

  Zhong, Shuping ^a   Johnson, Deborah L ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

c jun N terminal kinases; Elk 1; TATA binding protein

Indexed keywords

B DOUBLE PRIME 1; BUTYRATE RESPONSE FACTOR 1; DNA DIRECTED RNA POLYMERASE III; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TATA BINDING PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR BDP1; TRANSCRIPTION FACTOR BRF1; TRANSCRIPTION FACTOR ELK 1; TRANSCRIPTION FACTOR IIIB; UNCLASSIFIED DRUG; BRF1 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE 9; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE; PROTEIN SUBUNIT; PTPN18 PROTEIN, HUMAN; STRESS ACTIVATED PROTEIN KINASE 1; TATA BINDING PROTEIN ASSOCIATED FACTOR;

ANIMAL CELL; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE LOSS; GENE TARGETING; HUMAN; HUMAN CELL; MODULATION; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEPLETION; PROTEIN EXPRESSION; REGULATORY MECHANISM; RNA TRANSCRIPTION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PHYSIOLOGY;

ETS-DOMAIN PROTEIN ELK-1; GENE EXPRESSION REGULATION; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASE 9; PROMOTER REGIONS, GENETIC; PROTEIN SUBUNITS; PROTEIN TYROSINE PHOSPHATASES, NON-RECEPTOR; RNA POLYMERASE III; TATA-BINDING PROTEIN ASSOCIATED FACTORS; TATA-BOX BINDING PROTEIN; TRANSCRIPTION FACTOR TFIIIB; TRANSCRIPTION, GENETIC;

EID: 69149097522     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0904843106     Document Type: Article

References (37)

1. Chang L, Karin M (2001) Mammalian MAP kinase signalling cascades. Nature 410:37-40.
2. Davis RJ (2000) Signal transduction by the JNK group of MAP kinases. Cell 103:239-252.
3. Bode AM, Dong Z (2007) The functional contrariety of JNK. Mol Carcinog 8:591-598.
4. Ventura JJ, Hübner A, Zhang C, Flavell RA, Shokat KM, Davis RJ (2006) Chemical genetic analysis of the time course of signal transduction by JNK. Mol Cell 5:701-710.
5. Wang H-D, Trivedi A, Johnson DL (1997) Hepatitis B virus X protein induces RNA polymerase III-dependent gene transcription and increases cellular TATA-binding protein by activating the Ras signaling pathway. Mol Cell Biol 17:6838-6846.
6. Gomez-Roman N, Grandori C, Eisenman RN, White RJ (2003) Direct activation of RNA polymerase III transcription by c-Myc. Nature 421:290-294.
7. Woiwode A, et al. (2008) PTEN represses RNA polymerase III-dependent transcription by targeting the TFIIIB complex. Mol Cell Biol 12:4204-4214.
8. Hirsch HA, Jawdekar GW, Lee KA, Gu L, Henry RW (2004) Distinct mechanisms for repression of RNA polymerase III transcription by the retinoblastoma tumor suppressor protein. Mol Cell Biol 24:5989-5999.
9. Sutcliffe JE, Brown TR, Allison SJ, Scott PH, White RJ (2000) Retinoblastoma protein disrupts interactions required for RNA polymerase III transcription. Mol Cell Biol 20:9192-9202.
10. Crighton D, et al. (2003) p53 represses RNA polymerase III transcription by targeting TBP and inhibiting promoter occupancy by TFIIIB. EMBO J 22:2810-2820.
11. White RJ (2005) RNA polymerases I and III, growth control and cancer. Nat Rev Mol Cell Biol 1:69-78.
12. Johnson SA, Dubeau L, Johnson DL (2008) Enhanced RNA polymerase III-dependent transcription is required for oncogenic transformation. J Biol Chem 283:19184-19191.
13. Marshall L, Kenneth NS, White RJ (2008) Elevated tRNA (iMet) synthesis can drive cell proliferation and oncogenic transformation. Cell 1:78-89.
14. Fairley JA, Scott PH, White RJ (2003) TFIIIB is phosphorylated, disrupted and selectively released from tRNA promoters during mitosis in vivo. EMBO J 21:5841-5850.
15. Felton-Edkins ZA, Fairley JA, Graham EL, Johnston IM, White RJ, Scott PH (2003) The mitogen-activated protein (MAP) kinase ERK induces tRNA synthesis by phosphorylating TFIIIB. EMBO J 10:2422-32.
16. Hu P, Samudre K, Wu S, Sun Y, Hernandez N (2004) CK2 phosphorylation of Bdp1 executes cell cycle-specific RNA polymerase III transcription repression. Mol Cell 16:81-92.
17. Johnson SAS, Mandavia N, Wang HD, Johnson DL (2000) Transcriptional regulation of the human TATA-binding protein by Ras cellular signaling. Mol Cell Biol 20:5000-5009.
18. Zhong S, Zhang C, Johnson DL (2004) Epidermal growth factor enhances cellular TATA binding protein levels and induces RNA polymerase I- and III-dependent gene activity. Mol Cell Biol 12:5119-5129.
19. Zhong S, Fromm J, Johnson DL (2007) TBP is differentially regulated by c-Jun N-terminal kinase 1 (JNK1) and JNK2 through Elk-1, controlling c-Jun expression and cell proliferation. Mol Cell Biol 1:54-64.
20. Fromm J, Johnson SAS, Johnson DL (2008) EGFR1 and its variant, EGFRvIII, regulate TATA-binding protein expression through distinct pathways. Mol Cell Biol 28:4204-4214.
21. Johnson DL, Johnson SAS (2008) Cell biology. RNA metabolism and oncogenesis. Science 320:461-462.
22. Cabarcas S, Jacob J, Veras I, Schramm L (2008) Differential expression of the TFIIIB subunits Brf1 and Brf2 in cancer cells. BMC Mol Biol 9:74-78.
23. Mayer C, Bierhoff H, Grummt I (2005) The nucleolus as a stress sensor: JNK2 inactivates the transcription factor TIF-IA and down-regulates rRNA synthesis. Genes Dev 19:933-941.
24. Marshall L, White RJ (2008) Non-coding RNA production by RNA polymerase III is implicated in cancer. Nat Rev Cancer 8:911-914.
25. Johnson SAS, Zheng C, Fromm J, Willis I, Johnson DL (2007) Mammalian Maf1 is a negative regulator of transcription by all three nuclear RNA polymerases. Mol Cell 26:1-13.
26. Wang HD, Trivedi A, Johnson DL (1997) Hepatitis B virus X protein induces RNA polymerase III-dependent gene transcription and increases cellular TATA-binding protein by activating the Ras signaling pathway. Mol Cell Biol 17:6838-6846.
27. Felton-Edkins ZA, White RJ (2002) Multiple mechanisms contribute to the activation of RNA polymerase III transcription in cells transformed by papovaviruses. J Biol Chem 277:48182-48191.
28. Daly NL, et al. (2005) Deregulation of RNA polymerase III transcription in cervical epithelium in response to high-risk human papillomavirus. Oncogene 24:880-888.
29. Ying TH, Hsieh YH, Hsieh YS, Liu JY (2008) Antisense oligonucleotide Elk-1 suppresses the tumorigenicity of human hepatocellular carcinoma cells. Cell Biol Int 32:210-216.
30. Goodfellow SJ, Innes F, Derblay LE, MacLellan WR, Scott PH, White RJ (2006) Regulation of RNA polymerase III transcription during hypertrophic growth. EMBO J 25:1522-1533.
31. Sabapathy K, Hochedlinger K, Nam SY, Bauer A, Karin M, Wagner EF (2004) Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation. Mol Cell 15:713-725.
32. Tafolla E, Wang S, Wong B, Leong J, Kapila YL (2005) JNK2 oppositely regulate p53 in signaling linked to apoptosis triggered by an altered fibronectin matrix: JNK links FAK and p53. J Biol Chem 280:19992-19999.
33. Yang SH, Whitmarsh AJ, Davis RJ, Sharrocks AD (1998) Differential targeting of MAP kinases to the ETS-domain transcription factor Elk-1. EMBO J 17:1740-1749.
34. Hess P, Pihan G, Sawyers CL, Flavell RA, Davis RJ (2002) Survival signaling mediated by c-Jun NH(2)-terminal kinase in transformed B lymphoblasts. Nat Genet 32:201-205.
35. She QB, Chen N, Bode AM, Flavell RA, Dong Z (2002) Deficiency of c-Jun-NH(2)-terminal kinase-1 in mice enhances skin tumor development by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 62:1343-1348.
36. Sakurai T, Maeda S, Chang L, Karin M (2006) Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation. Proc Natl Acad Sci USA 103:10544-10551.
37. Chen N, et al. (2001) Suppression of skin tumorigenesis in c-Jun NH(2)-terminal kinase-2-deficient mice. Cancer Res 61:3908-3912.